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In the current study, we have exemplified the use of Bayesian neural networks for breast
cancer classification using the evidence procedure. The optimal Bayesian network has
81% overall accuracy in correctly classifying the true status of breast cancer patients,
59% sensitivity in correctly detecting the malignancy and 83% specificity in correctly
detecting the non-malignancy. The area under the receiver operating characteristic curve
(0.7940) shows that this is a moderate classification model.
Keywords:
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Introduction
Early detection of breast cancer can reduce the deadly threat to life. Including the
well-known “Gail model” (Gail et al., 1989), a number of other statistical models
have been proposed to assess the risk of being diagnosed with breast cancer
(Claus, Risch, & Thompson, 1993; Domchek et al., 2003; van Asperen et al.,
2004). However, these models imposed some limitations in their use of risk
prediction (Amir et al., 2003; Euhus, Leitch, Huth, & Peters, 2002).
The objective of the current study is to develop a better statistical model to
correctly classify the malignant breast cancer patients with their demographic
factors and previous mammogram results using a multi-layer perceptron (MLP), a
type of feedforward neural network. Although there exist several other models
based on neural networks with the same intention, few of them have make use of
the evidence approach with automatic relevance determination (ARD) prior for
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network regularization. We have selected the optimal network based on the model
evidence (or cost function) as oppose to the classical minimum square error.
In order to train MLPs, we have considered two different approaches. In the
first approach, a MLP is trained in the standard setting without incorporating any
prior probabilities in their weight structure, where the later approach is based on
Bayesian evidence procedure and the posterior probabilities of malignancy (Hung,
Shanker, & Hu, 2002) have been obtained. These probabilities have been used as
an initial measure for risk of diagnosing with incident breast cancer.
The advantage of neural networks over the other models is that, it is a selflearning model which is free of statistical assumptions. This allows neural
network process to be considered as a generalization of existing statistical
methodologies.
MLPs are used in a wide variety of fields including pattern recognition,
cognition and decision making (Ayer et al., 2010; Floyd, Lo, Yun, Sullivan, &
Kornguth, 1994; Orr, 2001; Wu et al., 1993), where they learn by examples
through training algorithms. Training can be supervised, where both inputs and
their corresponding outputs are fed to the network, or can be unsupervised, where
training data consist of only the inputs. During the training process, the weights
and the biases of the network are continuously adjusted to minimize the error
between the network’s output and the target outputs (Haykin, 1999). This process
leads weights and biases of the network to learn the knowledge or information
about the problem.
In the Bayesian approach, the uncertainty about the weight parameters is
estimated from data itself and represented by a probability distribution (Bishop,
1995). Apart from capturing the uncertainties and providing a natural
interpretation on regularization techniques, Bayesian approach has some other
useful aspects. Automatic relevance determination process is one of them, which
can be used to identify the relative importance of different inputs. This method
also allows making predictions by combining several networks (network
committees) in order to obtain improved performance.
Multi-Layer Perceptron (MLP)
MLPs are a popular class of feedforward networks which represent a multivariate
non-linear function mapping between a set of input and output variables (Bishop,
1995). These networks are organized as several interconnected layers. Each layer
is a collection of artificial neurons (nodes) where connections among the layers
have not formed any loops, hence the name feedforward. Data have been fed
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through the input layer, and then they pass through the hidden layer, and final
outcome is given by the output layer.
The complexity of a MLP is directly proportional to the number of hidden
nodes. It has been shown that a network with one hidden layer accompanied by
sufficient number of hidden nodes is capable of approximating any continuous
function (Hornik, Stinchcombe, & White, 1989). Therefore, we have considered a
MLP with one hidden layer (Figure 1) and the final outcome is given by (1).

Figure 1. A multi-layer perceptron network (MLP)

M
 d
y  x; w   g  a   g   w1 2j  h   wji1 xi
 i 0
 j 0





(1)

During the training process, the goal is to minimize the difference between
the actual and network predictions by adjusting the weights (including biases)
using some optimization algorithms. A well trained MLP is capable of making
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reasonable predictions to unseen data, which is known as generalization. This is
achieved by incorporating the regularization techniques like weight decay (Bishop,
1995). Next, we discuss some theory related to MLP for a two-class classification
problem.
Two-Class Classification Problem
For a two class classification, logistic sigmoid is selected as the activation
function in the output layer. This is the activation function “g” in (1), and has the
form of

y  x; w  

1
1  exp  a 

(2)

In the Bayesian context, the y (x; w) can be interpreted as the probability of
membership in class C1 given the input vector x. The probability of membership
of class C2 is then given by (1 – y (x; w)).
MLP with Maximum Likelihood (Standard Network)
Network training (minimizing the difference between the actual and network
predictions) can be done in two ways, using conventional maximum likelihood
and Bayesian approaches. In maximum likelihood, a single set of most likely
values for the weights are found whereas in Bayesian, a probability distribution
for weights is obtained to represent the uncertainty in the weight estimation.
For a set of training data {xn , tn} which are independent and identically
distributed, the likelihood can be written as in (3) (Assuming the data are coming
from a Bernoulli distribution). G (D| w) is the negative logarithm of the likelihood
which is defined as the cross entropy error function as given in (4).





1  y  x , w
 ln 1  y  x : w

P  D w   n p t n x n , w   n y  x n , w



tn

G  D w   t n ln y  x n : w  1  t n
n

n

n

1t n

(3)
(4)

Instead of maximizing the likelihood (since it is a monotonically decreasing
function), it is more convenient to minimize the cross-entropy. When training the
standard MLP in our analysis we have used this error function. The predictions on
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new data are made using the optimal set of weights through the maximum
likelihood method.
MLP with Bayesian Techniques
In training a MLP, weights are adjusted whenever a new data point is presented to
the network. A probability distribution which contains the degree of confidence
associated with each different weight can be used to represent this uncertainty.
The choice of prior distribution and about the corresponding posterior distribution
will be discussed shortly.
Network Regularization and Gaussian Prior
Smooth network mapping can be obtained by introducing network regularization
techniques. This will lead for better generalization. In the simplest setting we have
used a weight decay regularizer Ew of the form (5).
Ew 

1
w
2

2

(5)

As smaller weights (i.e a smaller Ew) are preferred for network weights, we
have generated the weights from a zero mean Gaussian prior (6) initially.

P  w 

1
2
 
exp   w  
exp   Ew 
Z w  
 2
 Z w  
1

(6)

 2 
where Z w  
 and, α is the inverse variance of the distribution which is
 
known as the hyper-parameter of the prior distribution. As a part of Bayesian
learning we can optimize the hyper-parameter α (evidence procedure).
w2

Posterior Distribution of Weights
The posterior probability distribution for weights can be determined according to
the Bayes’ theorem by incorporating the above prior (6) and the data likelihood
(3),
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P  w D 



1
exp  G  D w   Ew
Zs

  Z1 exp  S  w

(7)

s

where Zs is the normalization constant and S (w) is the regularized cost function.
The most probable weight vector wMP is found by maximizing the posterior, or
minimizing the regularized cost function. From the second order Taylor series
expansion of S (w) around its minimum wMP, we can obtain the following
approximation.
S  w  S  wMP  

1
T
 w  wMP  A  w  wMP 
2

(8)

Where A denotes the Hessian matrix of the regularized cost function. This leads to
the Gaussian approximation to posterior distribution as given in (9) where Z s* is
the normalization constant.

P  w D 

1
1


exp   S  wMP   wT Aw 
*
zs
2



(9)

Using the above posterior distribution, obtain the network predictions for the
probability that a new input vector x* belongs to class C1 as in (10). Although this
prediction is not directly achievable, we can use marginalized predictions to
obtain the results as suggested by (MacKay, 1992):
P  C1 x* , D    P  C1 x* , w P  w D  dw   y  x, wP  w D  dw

(10)

The Evidence Procedure
Prior to finding the above wMP , it is needed to find the most probable hyperparameter αMP , which maximizes the posterior probability of weights in Bayesian
setting (MacKay, 1996) .This αMP is obtained using the evidence p (D| α), by
integrating the product of data likelihood and the prior distribution of the weights
as given in (11).
p  D     p  D w  p  w   d
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After several modifications, the logarithm of the evidence can be
represented as in (12). The first term is the negative value of the regularized cost
function, and the next two terms are the Occam factors that represent the ratio of
posterior volume to prior volume. A network with higher number of hidden nodes
has a large prior volume and thus, has a small Occam factor. Hence, these Occam
factors act to penalize complex models and the evidence represents a trade-off
between the accuracy and the complexity (MacKay, 1992).

log E  S  w   log  OCCw   log  OCC 

(12)

Periodically re-estimate α according to (13), in order to get the greatest log
evidence value where γ represents the effective number of weights whose values
are controlled by the data rather than by the prior. Using that αMP we can calculate
the wMP (Thodberg, 1996). More details regarding this can be find in (Bishop,
1995).

 New 


2 Ew

(13)

The Automatic Relevance Determination
In the Bayesian setting, we can associate a separate hyper-parameter to each input
variable which represents the inverse variance of the prior distribution of the
weights fanning out from that input (Nabney, 2002). Optimal values for these
hyper-parameters are obtained using the evidence procedure. So the weights
connected to irrelevant inputs are automatically set to small values and this is
known as the ARD approach.
Committees
We can form a committee of networks to improve the prediction accuracies
by combining several networks with different architectures. These networks can
have different numbers of hidden nodes and/or they can be trained with different
random initializations.
The simplest form of a committee, which involves taking the average
predictions of the outputs of the L networks, is given by (14). This will improve
the accuracy of the predictions over an individual network output (Nabney, 2002).
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yCOM  x  

1 L
 yi  x 
L i 1

(14)

Methodology
Implementation of MLPs
Study Population
The data for this study are taken from Breast Cancer
Surveillance Consortium (Barlow et al., 2006) for the period 1996 to 2002. The
participating registries have obtained annual approvals from its institutional
review board.
The data sample contains the information on menopausal type, age, breast
density, ethnicity (Hispanic), body mass index (BMI), age at first birth, personal
or family history of breast cancer, prior breast procedures, results of the last
mammogram, type of menopause and current hormone therapy for each white
woman. These women were aged from 35 to 84 years, and more details are
available in Table 1.
Implementation of the Standard and Bayesian MLPs
Training and testing data sets were created by partitioning the whole data sets
each with 75% and 25% of data. A random sample out of the non-malignant
group in the training set is selected and merged that with the malignant group in
order to obtain a balanced training set. Table 2 represents the composition of data.
Different MLPs were trained using both standard and Bayesian approaches
with varying number of hidden nodes from 1 to 25. For all of these MLPs, a
logistic sigmoid activation function and scaled conjugate gradient (SCG) training
algorithm were used. SCG is selected as it is a faster training algorithm compared
to other algorithms (Penny & Roberts, 1999).
The standard MLP is trained using 10 fold cross-validation method and
without any weight regularization. In 10 fold cross-validation, the training set is
divided into 10 distinct segments, where 9 of those are used to train the network
while the remaining segment is used for validation. This process is repeated for
each of the 10 possible choices of the segments which are omitted from the
training process and the validation errors (cross-entropy error) are averaged over
all 10 results. The best network (with the corresponding hidden nodes) in this
approach is the one with the smallest average cross-entropy in the validation data
set (Kline & Berardi, 2005).
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Table 1. Details of the Study Population
Malignant (%)
1

2

3

Total
Menopausal Type ( X1)

Not Malignant (%)

Total

1053

6.47

15218

93.53

16271

100.00

Premenopausal
Postmenopausal

227
826

21.56
78.44

2882
12336

18.94
81.06

3109
13162

19.11
80.89

35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84

6
72
137
168
150
141
131
96
93
59

0.57
6.84
13.01
15.95
14.25
13.39
12.44
9.12
8.83
5.60

496
788
2355
2695
1872
1663
1533
1477
1343
996

3.26
5.18
15.48
17.71
12.30
10.93
10.07
9.71
8.83
6.54

502
860
2492
2863
2022
1804
1664
1573
1436
1055

3.09
5.29
15.32
17.60
12.43
11.09
10.23
9.67
8.83
6.48

2.94
38.46
48.05
10.54

2575
5319
4993
2331

16.92
34.95
32.81
15.32

2606
5724
5499
2442

16.02
35.18
33.80
15.01

97.44
2.56

12476
2742

81.98
18.02

13502
2769

82.98
17.02

41.03
30.96
17.19
10.83

4969
4404
3304
2541

32.65
28.94
21.71
16.70

5401
4730
3485
2655

33.19
29.07
21.42
16.32

65.72
14.62
19.66

7654
3412
4152

50.30
22.42
27.28

8346
3566
4359

51.29
21.92
26.79

72.46
23.93
3.61

8515
5077
1626

55.95
33.36
10.68

9278
5329
1664

57.02
32.75
10.23

68.00
32.00

8925
6293

58.65
41.35

9641
6630

59.25
40.75

98.01
1.99

13244
1974

87.03
12.97

14276
1995

87.74
12.26

54.70
23.74
21.56

7000
5336
2882

46.00
35.06
18.94

7576
5586
3109

46.56
34.33
19.11

37.99
40.46
21.56

6382
5954
2882

41.94
39.12
18.94

6782
6380
3109

41.68
39.21
19.11

Age Group ( X2)

Breast Density ( X3)

Almost entirely fat
31
Scattered fibroglandular densities
405
Heterogeneously dense
506
Extremely dense
111
4 Hispanic (X4)
No
1026
Yes
27
5 BMI (X5)
10-24.99
432
25-29.99
326
30-34.99
181
35 or more
114
6 Age at First Birth ( X6)
Age<30
692
Age 30 or greater
154
Nulliparous
207
7 Number of first degree relatives with breast cancer ( X 7)
Zero
763
One
252
Two or more
38
8 Previous breast procedure ( X8)
No
716
Yes
337
9 Result of last mammogram before the index mammogram ( X 9)
Negative
1032
False positive
21
10 Surgical menopause ( X10)
Natural
576
Surgical
250
Unknown
227
11 Current hormone therapy( X11)
No
400
Yes
426
Unknown or not menopausal
227
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Table 2. Summary of the training and testing data sets
Data set

Malignant

Non-Malignant

Total

Training set
Test set
Total

829
224
1053

1658
3030
4688

2487
3254
5741

Under the Bayesian approach, four types of networks were trained with
different weight regularization techniques. The first network is trained using 10
fold cross validation along with a weight regularization. The second and third
types of the networks are trained using Bayesian evidence procedure, one without
and the other with ARD prior. For both of the above types, 10 different networks
were trained with 10 different random initializations to examine the effect of local
minima on solutions, and they were taken to construct the network committees.
The optimal MLP with the lowest average regularized cost function in the training
data (or the highest average log evidence) is then selected and used to predict the
posterior probability of malignancy by simply averaging 10 network predictions
from each committee. Additionally, a same type of neural network with one
hidden node was built for a comparison, which is functionally equivalent to a
logistic regression model.
As the final network type, 10 different networks were trained on 10 different
random samples with varying number of hidden nodes along with evidence
process and ARD prior. The best MLP is selected using the minimum of the
regularized cost function.
Model Evaluation
The selected ANN models are evaluated based on their accuracy, sensitivity,
specificity values and the area under the receiver operating characteristic curve
(AUC) for the testing data (Bradley, 1997; Friedman & Wyatt, 2005). The
proportions of correctly identified malignant and non-malignant women from the
ANN models are known as the model accuracies. The proportions of actual
malignant patients who are correctly identified from the models are known as the
sensitivities and the proportions of non-malignant women who are correctly
identified from the models are known as the specificities.
A perfect desirable predictor would be described as 100% sensitive (i.e.
predicting all people from the malignant group as malignant) and 100% specific
(i.e. predicting all non-malignant people as non-malignant). However, for any test,
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there is usually a trade-off between these two measures, and this can be
represented graphically by a receiver operating characteristic curve.

Results
The summary of our six optimal network types is given in Table 3. Overall
accuracy in the logistic network (6 th MLP in the table) is lower than all other
MLPs except for the MLP trained without ARD prior. Moreover it has the second
lowest sensitivity and specificity values with the highest error. However, these
models are not directly comparable in terms of their errors, as they have different
settings and different training samples.
Table 3. Classification summary of the different MLP
No

MLP Type

Error(Cross
Entropy/Cost)

Accuracy

Sensitivity

Specificity

1

Standard MLP

641.96(valid error
16.50)

78.43%

55.36%

80.13%

2

MLP with weight regularization

434.77(valid error
8.28)

74.09%

53.57%

75.61%

3

MLP with evidence, but without
ARD prior

548.63

72.99%

60.71%

73.89%

4

MLP with both evidence and
ARD prior

582.28

74.15%

59.82%

75.21%

5

MLP trained on different samples
with evidence and ARD prior

908.78

81.35%

59.38%

82.97%

6

MLP with one hidden node
(logistic)

1123.10

73.11%

55.35%

74.42%

Out of these MLP types, the best network in terms of the highest accuracy
and specificity is found to be the MLP trained using different samples along with
both evidence procedure and ARD prior (5 th MLP). As can be seen, use of the
evidence procedure and the ARD prior has always resulted in better sensitivities.
However, use of weight regularization without any optimization (evidence
process) does not provide any significant improvement over the standard network
training process.
It can be concluded that use of weight regularization techniques along with
evidence process gives better results in Bayesian classification for most of the
time. Apart from that, use of ARD prior helps to identify the most contributing
variables to the network. Overall, Bayesian methods are preferred over the
standard method mainly because of the natural way of handling the weight
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regularization. By forming committees, we were able to reduce the network
training error.
The minimum and maximum prediction accuracies from these MLPs are
73% and 81%, respectively. Sensitivity values are varying from a minimum of
54% up to a maximum of 61% while specificity values are varying from 74% to
83%.

Figure 2. The receiver operating characteristic curves and the AUC values

The AUC values of all the above MLPs are greater than 70%, which implies a
moderate classification model. Figure 2 represents the receiver operating
characteristic curves with the corresponding AUC values. The posterior
probabilities of malignancy were obtained from the best Bayesian MLP network
selected.
ARD prior identifies the relevant importance of the inputs in the network.
Table 4 includes the rankings of the variable based on these hyper-parameter
values. Risk factors with smaller hyper-parameters are highly contributing to the
model outcome. Being in the age group 75 to 79 is the most critical factor in
diagnosing with malignant breast cancer. Having a prior false positive
mammogram can be an indication of malignant breast cancer. In accordance with
cancer literature, risk factors such as having heterogeneously or extremely dense
breast densities, and having a BMI of 35 or more are significantly contributing to
the model.
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Table 4. Rankings of the attributable variables based on the ARD prior
Rank

Alpha
(hyper-parameter)

Variable

1

0.3841

agegrp9

Age group 75-79

Risk Group

2

0.5550

lastmamm

Result of last mammogram before the index mammogram
- False positive

3

0.6489

density3

Density - Heterogeneously dense

4

0.6846

density4

Density - Extremely dense

5

0.8251

bmi4

35 or more

6

1.3072

agegrp2

Age group 40-44

7

1.3872

agegrp7

Age group 65-69

8

1.6989

hispanic

Hispanic or not - Yes

9

1.7403

nrelbc2

Number of first degree relatives with breast cancer - 2 or
more

10

1.9510

hrtYes

Current hormone therapy – Yes

11

2.0528

agegrp10

Age group 80-84

12

2.0826

bmi2

25-29.99

13

2.1980

agegrp8

Age group 70-74

14

2.2112

hrtNo

Current hormone therapy - No

15

2.8161

agegrp6

Age group 65-69

16

2.9341

bmi3

30-34.99

17

3.2299

agegrp5

Age group 55-59

18

3.6520

nrelbc1

Number of first degree relatives with breast cancer - One

19

3.7138

surgnatural

Surgical menopause - Natural

20

4.2249

agegrp4

Age group 50-54

21

5.0616

surgsurgical

Surgical menopause - Surgical

22

5.1547

brstproc

Previous breast procedure - Yes

23

5.7224

density2

Density - Scattered fibroglandular densities

24

7.2989

menopaus

Postmenopausal or age>=55

25

10.1388

agenulli

Age at first birth - Nulliparous

26

10.5538

agegrp3

Age group - 45-49

27

11.4664

agegreater30

Age at first birth - Age 30 or greater
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Conclusion
A breast cancer detection model was introduced using artificial neural network
theory. With the intention of having a better classification, different types of
MLPs were developed. These models are trained using the standard and Bayesian
techniques. The first two models were validated using 10-fold cross validation
and we have constructed committees for the other models. Finally all MLPs were
tested on a new set of test data.
The advantage of Bayesian MLP is that it gives the posterior probabilities
for classification which can be used as a priori risk of diagnosing with breast
cancer. The evidence procedure is used for the network regularization along with
ARD prior. Use of ARD prior did not make any significant difference in the
accuracy of our optimal MLP. Use of committees also did not show much
difference in the overall results compared to the single network predictions alone.
However, this has helped to give a low variance in the predictions.
The highest accuracy which was obtained from one of the Bayesian MLP is
about 81% and this is a significant improvement over the other methods which
used the same set of real data in terms of the discriminative accuracy. ROC curve
provides information about a model’s classification efficiency. A good
classification model was obtained for the third and the fifth MLP with more than
75% area under the ROC curve. The model may be further improved by
considering more relevant risk factors and more recent data, such as different
races because ethnicity is one of the significant risk factors that contributes to the
malignancy of breast cancer (Xu, Kepner, & Tsokos, 2011).
It was also confirmed that ANN may have an important role in improving
the accuracy and consistency of medical diagnosis. The proposed approach in
developing the ANN model is free of assumptions, as opposed to parametric
regression and hence increases the validity of our findings.
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